Jazz Pharmaceuticals PLC (JAZZ)
Total asset turnover
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 3,809,840 | 3,569,430 | 2,999,690 | 2,284,420 | 2,097,480 |
Total assets | US$ in thousands | 11,393,400 | 10,835,300 | 12,298,600 | 6,535,900 | 5,538,900 |
Total asset turnover | 0.33 | 0.33 | 0.24 | 0.35 | 0.38 |
December 31, 2023 calculation
Total asset turnover = Revenue ÷ Total assets
= $3,809,840K ÷ $11,393,400K
= 0.33
The total asset turnover ratio for Jazz Pharmaceuticals plc has shown some fluctuation over the past five years. In 2023 and 2022, the ratio remained consistent at 0.34, indicating that the company generated $0.34 in revenue for every dollar of total assets.
In 2021, there was a slight decrease in the ratio to 0.25, suggesting that the company was less efficient in utilizing its assets to generate sales compared to the previous years. However, this was followed by an increase in 2022, showing some improvement.
The highest total asset turnover ratio was observed in 2019 at 0.39, indicating that the company was more effective in generating revenue from its assets that year.
Overall, the total asset turnover ratio for Jazz Pharmaceuticals plc fluctuated between 0.25 and 0.39 over the five-year period, reflecting variations in the company's efficiency in utilizing its assets to generate sales. Further analysis would be needed to understand the specific factors driving these fluctuations and to assess the company's overall asset management efficiency.
Peer comparison
Dec 31, 2023